VVR - IAS Exam Preparation
Current Affairs:(Polity, Governance and International Relation)
INDIA, NETHERLANDS SIGN MOU FOR DEVELOPMENT OF MEASLESRUBELLA VACCINES :
India and Netherlands have signed a Memorandum of Understanding (MoU) for the development of Measles- Rubella Vaccines.
Key facts:
- The MoU was signed under Make in India initiative of Union government in the presence of the Netherlands Prime Minister Mark Rutte during his visit to India.
- The vaccine will be manufactured by Bharat Immunologicals and Biologicals Corporation Ltd (BIBCOL) at its plant at Chola, Uttar Pradesh. Translational Vaccinology (INTRAVACC) a government-based institute of Netherlands will provide technical support for the development of vaccine.
- INTRAVACC institute is part of Netherlands’ Ministry of Health, Welfare and Sport. It is internationally renowned for vaccine development and has a long history in technology transfer.
- BIBCOL is a Central Public Sector Unit (CPSU) under the Department of Biotechnology of Union Ministry of Science & Technology. It was established as a PSU in 1989, with the aim to achieve self-sufficiency for the nation with respect to production and supply of high quality polio vaccine and other biologicals.
- During India’s immunisation programme BIBCOL had supplied billions of doses of oral polio vaccine and had played a major role in making India polio free.